Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dayer

Showing results (91-100 of 283) with videos related to

Pageof 29
Sort By:
AIDS (London, England)|July 1, 1993
The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysisA Burgess, M Dayer, J Catalan, et al.
American Journal of Respiratory Cell and Molecular Biology|March 1, 1996
Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gammaB Galve-de Rochemonteix, L P Nicod, J M Dayer
The American Journal of Physiology|May 1, 1987
Interleukin-1 decreases renal sodium reabsorption: possible mechanism of endotoxin-induced natriuresisJ Caverzasio, R Rizzoli, J M Dayer, et al.
Annals of the New York Academy of Sciences|May 28, 1994
Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytesL P Nicod, B Galve-De-Rochemonteix, J M Dayer
Current Opinion in Rheumatology|May 3, 2001
Anti-interleukin-1 therapy in rheumatic diseasesJ M Dayer, U Feige, C K Edwards, et al.
American Journal of Respiratory Cell and Molecular Biology|June 1, 1990
Dissociation between allogeneic T cell stimulation and interleukin-1 or tumor necrosis factor production by human lung dendritic cellsL P Nicod, B Galve-de Rochemonteix, J M Dayer
The Journal of Clinical Investigation|July 1, 1995
The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptorD Burger, R Chicheportiche, J G Giri, et al.
Molecular Psychiatry|March 1, 1997
Both soluble and membrane-associated TNF activate brain microvascular endothelium: relevance to multiple sclerosisD Burger, J Lou, J M Dayer, et al.
The Journal of Clinical Investigation|November 1, 1979
Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cellsJ M Dayer, J Bréard, L Chess, et al.
Immunology Letters|August 1, 1990
Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages)A Ferrante, L Kumaratilake, C M Rzepczyk, et al.
Pageof 29

Showing results (91-100 of 283) with videos related to

Sort By:
Pageof 29
AIDS (London, England)|July 1, 1993
The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysisA Burgess, M Dayer, J Catalan, et al.
American Journal of Respiratory Cell and Molecular Biology|March 1, 1996
Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gammaB Galve-de Rochemonteix, L P Nicod, J M Dayer
The American Journal of Physiology|May 1, 1987
Interleukin-1 decreases renal sodium reabsorption: possible mechanism of endotoxin-induced natriuresisJ Caverzasio, R Rizzoli, J M Dayer, et al.
Annals of the New York Academy of Sciences|May 28, 1994
Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytesL P Nicod, B Galve-De-Rochemonteix, J M Dayer
Current Opinion in Rheumatology|May 3, 2001
Anti-interleukin-1 therapy in rheumatic diseasesJ M Dayer, U Feige, C K Edwards, et al.
American Journal of Respiratory Cell and Molecular Biology|June 1, 1990
Dissociation between allogeneic T cell stimulation and interleukin-1 or tumor necrosis factor production by human lung dendritic cellsL P Nicod, B Galve-de Rochemonteix, J M Dayer
The Journal of Clinical Investigation|July 1, 1995
The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptorD Burger, R Chicheportiche, J G Giri, et al.
Molecular Psychiatry|March 1, 1997
Both soluble and membrane-associated TNF activate brain microvascular endothelium: relevance to multiple sclerosisD Burger, J Lou, J M Dayer, et al.
The Journal of Clinical Investigation|November 1, 1979
Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cellsJ M Dayer, J Bréard, L Chess, et al.
Immunology Letters|August 1, 1990
Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages)A Ferrante, L Kumaratilake, C M Rzepczyk, et al.
Pageof 29